Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
The global Influenza Medication market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Influenza Medication volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza Medication market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Influenza Medication in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Influenza Medication manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International GmbH (Novartis AG)
Sun Pharmaceutical Industries
Mylan
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other
Segment by Application
Hospitals
Clinics
Pharmacies
Others
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
The global Influenza Medication market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Influenza Medication volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza Medication market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Influenza Medication in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Influenza Medication manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International GmbH (Novartis AG)
Sun Pharmaceutical Industries
Mylan
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other
Segment by Application
Hospitals
Clinics
Pharmacies
Others
Table of Contents
Executive Summary
1 Industry Overview of Influenza Medication
1.1 Definition of Influenza Medication
1.2 Influenza Medication Segment by Type
1.2.1 Global Influenza Medication Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.2.5 Amantadine
1.2.6 Rimantadine
1.2.7 Inosine
1.2.8 Other
1.3 Influenza Medication Segment by Applications
1.3.1 Global Influenza Medication Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Global Influenza Medication Overall Market
1.4.1 Global Influenza Medication Revenue (2014-2025)
1.4.2 Global Influenza Medication Production (2014-2025)
1.4.3 North America Influenza Medication Status and Prospect (2014-2025)
1.4.4 Europe Influenza Medication Status and Prospect (2014-2025)
1.4.5 China Influenza Medication Status and Prospect (2014-2025)
1.4.6 Japan Influenza Medication Status and Prospect (2014-2025)
1.4.7 Southeast Asia Influenza Medication Status and Prospect (2014-2025)
1.4.8 India Influenza Medication Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Influenza Medication
2.3 Manufacturing Process Analysis of Influenza Medication
2.4 Industry Chain Structure of Influenza Medication
3 Development and Manufacturing Plants Analysis of Influenza Medication
3.1 Capacity and Commercial Production Date
3.2 Global Influenza Medication Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Influenza Medication
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Influenza Medication Production and Capacity Analysis
4.2 Influenza Medication Revenue Analysis
4.3 Influenza Medication Price Analysis
4.4 Market Concentration Degree
5 Influenza Medication Regional Market Analysis
5.1 Influenza Medication Production by Regions
5.1.1 Global Influenza Medication Production by Regions
5.1.2 Global Influenza Medication Revenue by Regions
5.2 Influenza Medication Consumption by Regions
5.3 North America Influenza Medication Market Analysis
5.3.1 North America Influenza Medication Production
5.3.2 North America Influenza Medication Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Influenza Medication Import and Export
5.4 Europe Influenza Medication Market Analysis
5.4.1 Europe Influenza Medication Production
5.4.2 Europe Influenza Medication Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Influenza Medication Import and Export
5.5 China Influenza Medication Market Analysis
5.5.1 China Influenza Medication Production
5.5.2 China Influenza Medication Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Influenza Medication Import and Export
5.6 Japan Influenza Medication Market Analysis
5.6.1 Japan Influenza Medication Production
5.6.2 Japan Influenza Medication Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Influenza Medication Import and Export
5.7 Southeast Asia Influenza Medication Market Analysis
5.7.1 Southeast Asia Influenza Medication Production
5.7.2 Southeast Asia Influenza Medication Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Influenza Medication Import and Export
5.8 India Influenza Medication Market Analysis
5.8.1 India Influenza Medication Production
5.8.2 India Influenza Medication Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Influenza Medication Import and Export
6 Influenza Medication Segment Market Analysis (by Type)
6.1 Global Influenza Medication Production by Type
6.2 Global Influenza Medication Revenue by Type
6.3 Influenza Medication Price by Type
7 Influenza Medication Segment Market Analysis (by Application)
7.1 Global Influenza Medication Consumption by Application
7.2 Global Influenza Medication Consumption Market Share by Application (2014-2019)
8 Influenza Medication Major Manufacturers Analysis
8.1 Daiichi Sankyo Company
8.1.1 Daiichi Sankyo Company Influenza Medication Production Sites and Area Served
8.1.2 Daiichi Sankyo Company Product Introduction, Application and Specification
8.1.3 Daiichi Sankyo Company Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Influenza Medication Production Sites and Area Served
8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
8.2.3 GlaxoSmithKline Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Natco Pharma
8.3.1 Natco Pharma Influenza Medication Production Sites and Area Served
8.3.2 Natco Pharma Product Introduction, Application and Specification
8.3.3 Natco Pharma Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 F. Hoffmann-La Roche
8.4.1 F. Hoffmann-La Roche Influenza Medication Production Sites and Area Served
8.4.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.4.3 F. Hoffmann-La Roche Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Teva Pharmaceutical
8.5.1 Teva Pharmaceutical Influenza Medication Production Sites and Area Served
8.5.2 Teva Pharmaceutical Product Introduction, Application and Specification
8.5.3 Teva Pharmaceutical Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Sandoz International GmbH (Novartis AG)
8.6.1 Sandoz International GmbH (Novartis AG) Influenza Medication Production Sites and Area Served
8.6.2 Sandoz International GmbH (Novartis AG) Product Introduction, Application and Specification
8.6.3 Sandoz International GmbH (Novartis AG) Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sun Pharmaceutical Industries
8.7.1 Sun Pharmaceutical Industries Influenza Medication Production Sites and Area Served
8.7.2 Sun Pharmaceutical Industries Product Introduction, Application and Specification
8.7.3 Sun Pharmaceutical Industries Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Mylan
8.8.1 Mylan Influenza Medication Production Sites and Area Served
8.8.2 Mylan Product Introduction, Application and Specification
8.8.3 Mylan Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Influenza Medication Market
9.1 Global Influenza Medication Market Trend Analysis
9.1.1 Global Influenza Medication Market Size (Volume and Value) Forecast 2019-2025
9.2 Influenza Medication Regional Market Trend
9.2.1 North America Influenza Medication Forecast 2019-2025
9.2.2 Europe Influenza Medication Forecast 2019-2025
9.2.3 China Influenza Medication Forecast 2019-2025
9.2.4 Japan Influenza Medication Forecast 2019-2025
9.2.5 Southeast Asia Influenza Medication Forecast 2019-2025
9.2.6 India Influenza Medication Forecast 2019-2025
9.3 Influenza Medication Market Trend (Product Type)
9.4 Influenza Medication Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Influenza Medication Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Influenza Medication
1.1 Definition of Influenza Medication
1.2 Influenza Medication Segment by Type
1.2.1 Global Influenza Medication Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.2.5 Amantadine
1.2.6 Rimantadine
1.2.7 Inosine
1.2.8 Other
1.3 Influenza Medication Segment by Applications
1.3.1 Global Influenza Medication Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Global Influenza Medication Overall Market
1.4.1 Global Influenza Medication Revenue (2014-2025)
1.4.2 Global Influenza Medication Production (2014-2025)
1.4.3 North America Influenza Medication Status and Prospect (2014-2025)
1.4.4 Europe Influenza Medication Status and Prospect (2014-2025)
1.4.5 China Influenza Medication Status and Prospect (2014-2025)
1.4.6 Japan Influenza Medication Status and Prospect (2014-2025)
1.4.7 Southeast Asia Influenza Medication Status and Prospect (2014-2025)
1.4.8 India Influenza Medication Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Influenza Medication
2.3 Manufacturing Process Analysis of Influenza Medication
2.4 Industry Chain Structure of Influenza Medication
3 Development and Manufacturing Plants Analysis of Influenza Medication
3.1 Capacity and Commercial Production Date
3.2 Global Influenza Medication Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Influenza Medication
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Influenza Medication Production and Capacity Analysis
4.2 Influenza Medication Revenue Analysis
4.3 Influenza Medication Price Analysis
4.4 Market Concentration Degree
5 Influenza Medication Regional Market Analysis
5.1 Influenza Medication Production by Regions
5.1.1 Global Influenza Medication Production by Regions
5.1.2 Global Influenza Medication Revenue by Regions
5.2 Influenza Medication Consumption by Regions
5.3 North America Influenza Medication Market Analysis
5.3.1 North America Influenza Medication Production
5.3.2 North America Influenza Medication Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Influenza Medication Import and Export
5.4 Europe Influenza Medication Market Analysis
5.4.1 Europe Influenza Medication Production
5.4.2 Europe Influenza Medication Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Influenza Medication Import and Export
5.5 China Influenza Medication Market Analysis
5.5.1 China Influenza Medication Production
5.5.2 China Influenza Medication Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Influenza Medication Import and Export
5.6 Japan Influenza Medication Market Analysis
5.6.1 Japan Influenza Medication Production
5.6.2 Japan Influenza Medication Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Influenza Medication Import and Export
5.7 Southeast Asia Influenza Medication Market Analysis
5.7.1 Southeast Asia Influenza Medication Production
5.7.2 Southeast Asia Influenza Medication Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Influenza Medication Import and Export
5.8 India Influenza Medication Market Analysis
5.8.1 India Influenza Medication Production
5.8.2 India Influenza Medication Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Influenza Medication Import and Export
6 Influenza Medication Segment Market Analysis (by Type)
6.1 Global Influenza Medication Production by Type
6.2 Global Influenza Medication Revenue by Type
6.3 Influenza Medication Price by Type
7 Influenza Medication Segment Market Analysis (by Application)
7.1 Global Influenza Medication Consumption by Application
7.2 Global Influenza Medication Consumption Market Share by Application (2014-2019)
8 Influenza Medication Major Manufacturers Analysis
8.1 Daiichi Sankyo Company
8.1.1 Daiichi Sankyo Company Influenza Medication Production Sites and Area Served
8.1.2 Daiichi Sankyo Company Product Introduction, Application and Specification
8.1.3 Daiichi Sankyo Company Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Influenza Medication Production Sites and Area Served
8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
8.2.3 GlaxoSmithKline Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Natco Pharma
8.3.1 Natco Pharma Influenza Medication Production Sites and Area Served
8.3.2 Natco Pharma Product Introduction, Application and Specification
8.3.3 Natco Pharma Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 F. Hoffmann-La Roche
8.4.1 F. Hoffmann-La Roche Influenza Medication Production Sites and Area Served
8.4.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.4.3 F. Hoffmann-La Roche Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Teva Pharmaceutical
8.5.1 Teva Pharmaceutical Influenza Medication Production Sites and Area Served
8.5.2 Teva Pharmaceutical Product Introduction, Application and Specification
8.5.3 Teva Pharmaceutical Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Sandoz International GmbH (Novartis AG)
8.6.1 Sandoz International GmbH (Novartis AG) Influenza Medication Production Sites and Area Served
8.6.2 Sandoz International GmbH (Novartis AG) Product Introduction, Application and Specification
8.6.3 Sandoz International GmbH (Novartis AG) Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sun Pharmaceutical Industries
8.7.1 Sun Pharmaceutical Industries Influenza Medication Production Sites and Area Served
8.7.2 Sun Pharmaceutical Industries Product Introduction, Application and Specification
8.7.3 Sun Pharmaceutical Industries Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Mylan
8.8.1 Mylan Influenza Medication Production Sites and Area Served
8.8.2 Mylan Product Introduction, Application and Specification
8.8.3 Mylan Influenza Medication Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Influenza Medication Market
9.1 Global Influenza Medication Market Trend Analysis
9.1.1 Global Influenza Medication Market Size (Volume and Value) Forecast 2019-2025
9.2 Influenza Medication Regional Market Trend
9.2.1 North America Influenza Medication Forecast 2019-2025
9.2.2 Europe Influenza Medication Forecast 2019-2025
9.2.3 China Influenza Medication Forecast 2019-2025
9.2.4 Japan Influenza Medication Forecast 2019-2025
9.2.5 Southeast Asia Influenza Medication Forecast 2019-2025
9.2.6 India Influenza Medication Forecast 2019-2025
9.3 Influenza Medication Market Trend (Product Type)
9.4 Influenza Medication Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Influenza Medication Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
